Cell sourcing and culture conditions for fibrin-based valve constructs

Tissue Engineering

Volumn 12, Issue 6, 2006, Pages 1489-1502

  Williams, Chrysanthi ^a,b   Johnson, Sandra L ^a   Robinson, Paul S ^a   Tranquillo, Robert T ^a,c  

^a University of Minnesota   (United States)

^b Bose Corporation   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BIOMEDICAL ENGINEERING; BODY FLUIDS; COLLAGEN; ENZYME INHIBITION; GROWTH KINETICS; HEART VALVE PROSTHESES;

DULBECCO'S MODIFIED EAGLE'S MEDIUM (DMEM); FIBROBLAST GROWTH FACTOR (FGF); HUMAN DERMAL FIBROBLASTS (HDF); PORCINE VALVE INTERSTITIAL CELLS (PVIC);

CELL CULTURE;

ANTIBIOTIC AGENT; ASCORBIC ACID; COLLAGEN; FIBRIN; FIBROBLAST GROWTH FACTOR; INSULIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; FIBRINOLYSIS; HEART VALVE PROSTHESIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST; TENSILE STRENGTH; TISSUE ENGINEERING;

ANIMALS; BIOPROSTHESIS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; FIBRIN; FIBROBLASTS; HEART VALVE PROSTHESIS; HEART VALVES; HUMANS; INFANT, NEWBORN; SKIN; SWINE; TISSUE ENGINEERING;

SUIDAE;

EID: 33746798859     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.12.1489     Document Type: Article

References (66)

1. Flanagan, T.C., and Pandit, A. Living artificial heart valve alternatives: a review. Eur. Cell Mater. 6, 28; discussion 45, 2003.
2. Sarraf, C.E., Harris, A.B., McCulloch, A.D., and Eastwood, M. Heart valve and arterial tissue engineering. Cell Prolif. 36, 241, 2003.
3. Schoen, F.J. Future directions in tissue heart valves: impact of recent insights from biology and pathology. J. Heart Valve Dis. 8, 350, 1999.
4. Schoen, F.J., and Levy, R.J. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. J. Biomed. Mater. Res. 47, 439, 1999.
5. Shinoka, T., Breuer, C.K., Tanel, R.E., Zund, G., Miura, T., Ma, P.X., Langer, R., Vacanti, J. P., and Mayer, J.E., Jr. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann. Thorac. Surg. 60(6 Suppl), S513, 1995.
6. Hoerstrup, S.P., Zund, G., Ye, Q., Schoeberlein, A., Schmid, A.C., and Turina, M.I. Tissue engineering of a bioprosthetic heart valve: stimulation of extracellular matrix assessed by hydroxyproline assay. Asaio J. 45, 397, 1999.
7. Sodian, R., Hoerstrup, S.P., Sperling, J.S., Daebritz, S.H., Martin, D.P., Schoen, F.J., Vacanti, J.P., and Mayer, J.E., Jr. Tissue engineering of heart valves: in vitro experiences. Ann. Thorac. Surg 70, 140, 2000.
8. Sodian, R., Hoerstrup, S.P., Sperling, J.S., Daebritz, S., Martin, D.P., Moran, A.M., Kim, B. S., Schoen, F.J., Vacanti, J.P., and Mayer, J.E., Jr. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 102(Suppl 3), III22, 2000.
9. Hoerstrup, S.P., Sodian, R., Daebritz, S., Wang, J., Bacha, E.A., Martin, D.P., Moran, A.M., Guleserian, K.J., Sperling, J.S., Kaushal, S., Vacanti, J.P., Schoen, F.J., and Mayer, J.E., Jr. Functional living trileaflet heart valves grown in vitro. Circulation 102(Suppl 3), III44, 2000.
10. Engelmayr, G.C., Jr., Hildebrand, D.K., Sutherland, F.W., Mayer, J.E., Jr., and Sacks, M.S. A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. Biomaterials 24, 2523, 2003.
11. Kim, W.G., Park, J.K., Park, Y.N., Hwang, C.M., Jo, Y.H., Min, B.G., Yoon, C.J., and Lee, T.Y. Tissue-engineered heart valve leaflets: an effective method for seeding autologous cells on scaffolds. Int. J. Artif. Organs 23, 624, 2000.
12. Athanasiou, K.A., Niederauer, G.G., and Agrawal, C.M. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 17, 93, 1996.
13. Schenke-Layland, K., Opitz, F., Gross, M., Doring, C., Halbhuber, K.J., Schirrmeister, F., Wahlers, T., and Stock, U.A. Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study. Cardiovasc. Res. 60, 497, 2003.
14. Taylor, P.M., Allen, S.P., Dreger, S.A., and Yacoub, M.H. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. J Heart Valve Dis 11, 298; discussion 306, 2002.
15. Shi, Y., Ramamurthi, A., and Vesely, I. Towards tissue engineering of a composite aortic valve. Biomed. Sci. Instrum. 38, 35, 2002.
16. Rothenburger, M., Volker, W., Vischer, J.P., Berendes, E., Glasmacher, B., Scheld, H.H., and Deiwick, M. Tissue engineering of heart valves: formation of a three-dimensional tissue using porcine heart valve cells. Asaio J. 48, 586, 2002.
17. Jockenhoevel, S., Zund, G., Hoerstrup, S.P., Chalabi, K., Sachweh, J.S., Demircan, L., Messmer, B.J., and Turina, M. Fibrin gel-advantages of a new scaffold in cardiovascular tissue engineering. Eur. J. Cardiothorac. Surg. 19, 424, 2001.
18. Neidert, M.R., and Tranquille, R.T. Tissue-engineered valves with commissural alignment. Tissue Eng. 12, 891, 2006.
19. Grassl, E.D., Oegema, T.R., and Tranquille, R.T. Fibrin as an alternative biopolymer to type-1 collagen for the fabrication of a media equivalent. J. Biomed. Mater. Res. 60, 607, 2002.
20. Gilbert, A., Evtushenko, M., and Nair, H. Purification of fibrinogen and virus removal using preparative electrophoresis. Ann. N. Y. Acad. Sci. 936, 625, 2001.
21. Tuan, T.L., and Grinnell, F. Fibronectin and fibrinolysis are not required for fibrin gel contraction by human skin fibroblasts. J. Cell. Physiol. 140, 577, 1989.
22. Tuan, T.L., Song, A., Chang, S., Younai, S., and Nimni, M.E. In vitro fibroplasia: matrix contraction, cell growth, and collagen production of fibroblasts cultured in fibrin gels. Exp. Cell Res. 223, 127, 1996.
23. Grassl, E.D., Oegema, T.R., and Tranquillo, R.T. A fibrin-based arterial media equivalent. J. Biomed. Mater. Res. A. 66, 550, 2003.
24. Long, J.L., and Tranquillo, R.T. Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol. 22, 339, 2003.
25. Ross, J.J., and Tranquillo, R.T. ECM gene expression correlates with in vitro tissue growth and development in fibrin gel remodeled by neonatal smooth muscle cells. Matrix Biol. 22, 477, 2003.
26. Taylor, P.M., Batten, P., Brand, N.J., Thomas, P.S., and Yacoub, M.H. The cardiac valve interstitial cell. Int. J. Biochem. Cell Biol. 35, 113, 2003.
27. Scott, M., and Vesely, I. Aortic valve cusp microstructure: the role of elastin. Ann. Thorac. Surg. 60(2 Suppl), S391, 1995.
28. Durbin, A.D., and Gotlieb, A.I. Advances towards understanding heart valve response to injury. Cardiovasc. Pathol. 11, 69, 2002.
29. Hoerstrup, S.P., Kadner, A., Melnitchouk, S., Trojan, A., Eid, K., Tracy, J., Sodian, R., Visjager, J.F., Kolb, S.A., Grunenfelder, J., Zund, G., and Turina, M.I. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 106(12 Suppl 1), 1143, 2002.
30. Engelmayr, G.C., Jr., Rabkin, E., Sutherland, F.W., Schoen, F.J., Mayer, J.E., Jr., and Sacks, M.S. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials 26, 175, 2005.
31. Schenke-Layland, K., Riemann, I., Opitz, F., Konig, K., Halbhuber, K.J., and Stock, U.A. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Matrix Biol 23, 113, 2004.
32. Stock, U.A., and Mayer, J.E., Jr. Tissue engineering of cardiac valves on the basis of PGA/PLA Co-polymers. J. Long Term Eff. Med. Implants 11, 249, 2001.
33. Masters, K.S., Shah, D.N., Walker, G., Leinwand, L.A., and Anseth, K.S. Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials. J. Biomed. Mater. Res. 71A, 172, 2004.
34. Taylor, P.M., Allen, S.P., and Yacoub, M.H. Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. J. Heart Valve Dis. 9, 150, 2000.
35. Butcher, J.T., and Nerem, R.M. Porcine aortic valve interstitial cells in three-dimensional culture: comparison of phenotype with aortic smooth muscle cells. J. Heart Valve Dis. 13, 478; discussion 485, 2004.
36. Hafizi, S., Taylor, P.M., Chester, A.H., Allen, S.P., and Yacoub, M.H. Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents. J. Heart Valve Dis. 9, 454, 2000.
37. Chester, A.H., Misfeld, M., and Yacoub, M.H. Receptor-mediated contraction of aortic valve leaflets. J. Heart Valve Dis. 9, 250; discussion 254, 2000.
38. Kershaw, J.D., Misfeld, M., Sievers, H.H., Yacoub, M.H., and Chester, A.H. Specific regional and directional contractile responses of aortic cusp tissue. J. Heart Valve Dis. 13, 798, 2004.
39. Khouw, I.M., van Wachem, P.B., Plantinga, J.A., Vujaskovic, Z., Wissink, M.J., de Leij, L.F., and van Luyn, M.J. TGF-beta and bFGF affect the differentiation of proliferating porcine fibroblasts into myofibroblasts in vitro. Biomaterials 20, 1815, 1999.
40. Stegemann, H., and Stalder, K. Determination of hydroxyproline. Clin. Chim. Acta. 18, 267, 1967.
41. Neidert, M.R., Lee, E.S., Oegema, T.R., and Tranquillo, R.T. Enhanced fibrin remodeling in vitro with TGF-beta1, insulin and plasmin for improved tissue-equivalents. Biomaterials 23, 3717, 2002.
42. Starcher, B. A ninhydrin-based assay to quantitate the total protein content of tissue samples. Anal. Biochem. 292, 125, 2001.
43. Kim, Y.J., Sah, R.L., Doong, J.Y., and Grodzinsky, A.J. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal. Biochem. 174, 168, 1988.
44. Labarca, C., and Paigen, K. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102, 344, 1980.
45. Kim, B.S., and Mooney, D.J. Engineering smooth muscle tissue with a predefined structure. J. Biomed. Mater. Res. 41, 322, 1998.
46. Invitrogen. Gibco Cell Culture Systems Catalog. 2004.
47. Cario, E., Jung, S., Harder D'Heureuse, J., Schulte, C., Sturm, A., Wiedenmann, B., Goebell, H., and Dignass, A.U. Effects of exogenous zinc supplementation on intestinal epithelial repair in vitro. Eur. J. Clin. Invest. 30, 419, 2000.
48. Smith-Mungo, L.I., and Kagan, H.M. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol. 16, 387, 1998.
49. Reitzer, L.J., Wice, B.M., and Kennell, D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J. Biol. Chem. 254, 2669, 1979.
50. Petch, D., and Butler, M. Profile of energy metabolism in a murine hybridoma: glucose and glutamine utilization. J. Cell Physiol. 161, 71, 1994.
51. Fitzpatrick, L., Jenkins, H.A., and Butler, M. Glucose and glutamine metabolism of a murine B-lymphocyte hybridoma grown in batch culture. Appl. Biochem. Biotechnol. 43, 93, 1993.
52. Lehninger, A. Principles of Biochemistry. New York: Worth Publishers Inc., 1982.
53. Clark, W.A., Jr. Selective control of fibroblast proliferation and its effect on cardiac muscle differentiation in vitro. Dev. Biol. 52, 263, 1976.
54. Corfield, V.A., and Hay, R.J. Effects of cystine or glutamine restriction on human diploid fibroblasts in culture. In Vitro 14, 787, 1978.
55. Elmore, E., and Swift, M. Growth of human skin fibroblasts in dialyzed fetal bovine serum. In Vitro 13, 837, 1977.
56. Austin, F.E., Turco, J., and Winkler, H.H. Rickettsia prowazekii requires host cell serine and glycine for growth. Infect. Immun. 55, 240, 1987.
57. Sukemori, S., and Sugimura, K. Stimulation of amino acid efflux from cells by extracellular serine. Cancer Biochem. Biophys. 13, 113, 1992.
58. Watanabe, J., Holinka, C.F., Anzai, Y., Kuramoto, H., and Gurpide, E. Effects of serine and glycine on proliferation of an Ishikawa cell variant. J. Steroid Biochem. 34, 165, 1989.
59. Guthold, M., Liu, W., Stephens, B., Lord, S.T., Hantgan, R.R., Erie, D.A., Taylor, R.M., Jr., and Superfine, R. Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1.3. Biophys. J. 87, 4226, 2004.
60. Thompson, J.I., and Czernuszka, J.T. The effect of two types of cross-linking on some mechanical properties of collagen. Biomed. Mater. Eng. 5, 37, 1995.
61. Hoffman-Kim, D., Maish, M.S., Krueger, P.M., Lukoff, H., Bert, A., Hong, T., and Hopkins, R. A. Comparison of three myofibroblast cell sources for the tissue engineering of cardiac valves. Tissue Eng. 11, 288, 2005.
62. Maish, M.S., Hoffman-Kim, D., Krueger, P.M., Souza, J.M., Harper, J.J., 3rd, and Hopkins, R.A. Tricuspid valve biopsy: a potential source of cardiac myofibroblast cells for tissue-engineered cardiac valves. J. Heart Valve Dis. 12, 264, 2003.
63. Sapienza, P., di Marzo, L., Borrelli, V., Sterpetti, A.V., Mingoli, A., Piagnerelli, R., and Cavallaro, A. Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression. Eur. J. Vase. Endovasc. Surg. 28, 89, 2004.
64. Levene, C.I., and Bates, C.J. Ascorbic acid and collagen synthesis in cultured fibroblasts. Ann. N. Y. Acad. Sci. 258, 288, 1975.
65. Padh, H. Cellular functions of ascorbic acid. Biochem. Cell. Biol. 68, 1166, 1990.
66. Walker, G.A., Masters, K.S., Shah, D.N., Anseth, K.S., and Leinwand, L.A. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ. Res. 95, 253, 2004.